24 related articles for article (PubMed ID: 4815)
1. Plasma beta-lipotropin levels in Parkinson's disease.
Wiesen M; Yahr MD; Krieger DT
J Neural Transm; 1982; 53(1):75-82. PubMed ID: 6278076
[TBL] [Abstract][Full Text] [Related]
2. On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.
Björkman S; Sievertsson H
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):79-81. PubMed ID: 18686
[TBL] [Abstract][Full Text] [Related]
3. alpha-MSH, MIF-I and melatonin: effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats.
Datta PC; King MG
Peptides; 1981; 2 Suppl 1():143-54. PubMed ID: 6115365
[TBL] [Abstract][Full Text] [Related]
4. Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.
Spirtes MA; Kostrzewa RM; Kastin AJ
Pharmacol Biochem Behav; 1975; 3(6):1011-5. PubMed ID: 4814
[TBL] [Abstract][Full Text] [Related]
5. Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain.
Christensen CW; Harston CT; Kastin AJ; Kostrzewa RM; Spirtes MA
Pharmacol Biochem Behav; 1976; 5(Suppl 1):117-20. PubMed ID: 13410
[TBL] [Abstract][Full Text] [Related]
6. alpha-MSH effects on novelty-induced defecation, plasma 11-OHCS and whole brain catecholamines in hypophysectomized rats.
Datta PC; King MG
Pharmacol Biochem Behav; 1980 May; 12(5):773-9. PubMed ID: 7393972
[TBL] [Abstract][Full Text] [Related]
7. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
8. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
Kostrzewa RM; Kastin AJ; Spirtes MA
Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
[TBL] [Abstract][Full Text] [Related]
9. CNS and pituitary effects of hypothalamic peptides and MSH.
Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
[TBL] [Abstract][Full Text] [Related]
10. Alpha-melanocyte-stimulating hormone and behavior.
Datta PC; King MG
Neurosci Biobehav Rev; 1982; 6(3):297-310. PubMed ID: 6294567
[TBL] [Abstract][Full Text] [Related]
11. [Role of alpha-MSH and related peptides in the central nervous system].
Delbende C; Jegou S; Tranchand-Bunel D; Leroux P; Tonon MC; Mocaër E; Pelletier G; Vaudry H
Rev Neurol (Paris); 1985; 141(6-7):429-39. PubMed ID: 2868517
[TBL] [Abstract][Full Text] [Related]
12. Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies.
Kastin AJ; Ehrensing RH; Olson RD; Coy DH
Int J Neurol; 1980; 14(2-4):205-9. PubMed ID: 6152908
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
